While VEGF has clearly defined roles for enhancing tumor cell migration via stimulation of angiogenesis, CCL-18 is a key factor in the chemotaxis of naïve T-cells and immune-suppression in the TME. The gene discussed is VEGFA; the disease is neoplasm.